Yoshiro Nakahara

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 2

Top Topics

Systemic Sclerosis

Ejection Fraction

Top Venues

Thoracic cancer

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata, Kageaki Watanabe, Yukio Hosomi, Hidehito Horinouchi, Yuichiro Ohe, Yoshiro Nakahara, Katsuhiko Naoki, Tetsuhiko Asao, Kazuhisa Takahashi, Sho Saeki, Takuro Sakagami, Kazuhisa Nakashima, Yukari Tsubata, Yu Fujita, Kazuyoshi Kuwano, Megumi Furuta, Jun Sakakibara Konishi, Mayu Ohuchi, Yuichi Ando, Hidenori Mizugaki, Akinobu Hamada
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older. Clinical pharmacology and therapeutics (2024)
Mitsuhiro Moda, Haruhiro Saito, Terufumi Kato, Ryo Usui, Tetsuro Kondo, Yoshiro Nakahara, Shuji Murakami, Kouji Yamamoto, Kouzo Yamada
Tumor invasion in the central airway is a risk factor for early-onset checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer. Thoracic cancer 11 (12) (2020)